These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28495231)

  • 1. Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption.
    Carriere N; Verloop D; Dupont C; Fontaine V; Tir M; Krystkowiak P; Blanchard A; Defebvre MM; Defebvre L
    Rev Neurol (Paris); 2017 Jun; 173(6):396-405. PubMed ID: 28495231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.
    Blin P; Dureau-Pournin C; Foubert-Samier A; Grolleau A; Corbillon E; Jové J; Lassalle R; Robinson P; Poutignat N; Droz-Perroteau C; Moore N
    Eur J Neurol; 2015 Mar; 22(3):464-71. PubMed ID: 25389031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
    Foulon S; Maura G; Dalichampt M; Alla F; Debouverie M; Moreau T; Weill A
    J Neurol; 2017 Jun; 264(6):1185-1192. PubMed ID: 28516332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
    Davis KL; Edin HM; Allen JK
    Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deaths in France: Characteristics, place of death, hospitalisations and use of palliative care during the year before death.
    Poulalhon C; Rotelli-Bihet L; Raso C; Aubry R; Fagot-Campagna A; Tuppin P
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):33-42. PubMed ID: 29203132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the prevalence of depression associated with healthcare use in France using administrative databases.
    Filipovic-Pierucci A; Samson S; Fagot JP; Fagot-Campagna A
    BMC Psychiatry; 2017 Jan; 17(1):1. PubMed ID: 28049496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive study of general practitioner's practices and knowledge about Parkinson's disease in the north of France.
    Aubignat M; Skierkowski H; Tir M
    Rev Neurol (Paris); 2024 Sep; 180(7):650-654. PubMed ID: 38556412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of breast, prostate, and colorectal cancer incidence using a French administrative database (general sample of health insurance beneficiaries).
    Doat S; Samson S; Fagot-Campagna A; Tuppin P; Menegaux F
    Rev Epidemiol Sante Publique; 2016 Jun; 64(3):145-52. PubMed ID: 27238161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Care pathway diversity of patients with multiple sclerosis between French regions].
    Blein C; Chamoux C; Reynaud D; Lepage V
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):385-394. PubMed ID: 30309672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health status of populations living in French overseas territories in 2012, compared with metropolitan France: An analysis of the national health insurance database].
    Filipovic-Pierucci A; Rigault A; Fagot-Campagna A; Tuppin P
    Rev Epidemiol Sante Publique; 2016 Jun; 64(3):175-83. PubMed ID: 27238162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trends in the prevalence and incidence of Parkinson's disease in Taiwan: A nationwide, population-based study.
    Liu WM; Wu RM; Lin JW; Liu YC; Chang CH; Lin CH
    J Formos Med Assoc; 2016 Jul; 115(7):531-8. PubMed ID: 26123636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sources of information on suicide attempts in the Nord - Pas-de-Calais (France). Contributions and limitations].
    Plancke L; Ducrocq F; Clément G; Chaud P; Haeghebaert S; Amariei A; Chan-Chee C; Goldstein P; Vaiva G
    Rev Epidemiol Sante Publique; 2014 Dec; 62(6):351-60. PubMed ID: 25454751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of healthcare reimbursement data to monitor syphilis epidemic: an alternative surveillance through the national health insurance database in France, 2011-2013.
    Ndeikoundam Ngangro N; Viriot D; Lucas E; Boussac-Zarebska M; Lot F; Dupin N; La Ruche G
    BMJ Open; 2018 Jul; 8(7):e020336. PubMed ID: 30037863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care pathways and healthcare use of stroke survivors six months after admission to an acute-care hospital in France in 2012.
    Tuppin P; Samson S; Fagot-Campagna A; Woimant F
    Rev Neurol (Paris); 2016; 172(4-5):295-306. PubMed ID: 27038535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database.
    Pierret C; Mainguy M; Leray E
    Rev Neurol (Paris); 2024 May; 180(5):429-437. PubMed ID: 38423846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term association between road traffic noise and healthcare demand generated by Parkinson's disease in Madrid, Spain.
    Díaz J; Martínez-Martín P; Rodríguez-Blázquez C; Vázquez B; Forjaz MJ; Ortiz C; Carmona R; Linares C
    Gac Sanit; 2018; 32(6):553-558. PubMed ID: 28343738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal disorders in Parkinson's disease: prevalence and health outcomes in a US claims database.
    Makaroff L; Gunn A; Gervasoni C; Richy F
    J Parkinsons Dis; 2011; 1(1):65-74. PubMed ID: 23939257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of drug reimbursement as markers of disease for epidemiological and cost analysis: The case of severe epilepsy in France].
    Fagnani F; Vespignani H; Kusnik-Joinville O; Bertrand M; Murat C; Lévy-Bachelot L; Kahane P
    Presse Med; 2013 Sep; 42(9 Pt 1):e285-92. PubMed ID: 23601908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature].
    Gallini A; Moisan F; Maura G; Carcaillon-Bentata L; Leray E; Haesebaert J; Bruandet A; Moutengou E; Luciano L; Weill A; Marin B; Gardette V
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S183-S197. PubMed ID: 28341166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.